162 related articles for article (PubMed ID: 37435228)
1. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.
Zhao H; Xie R; Zhang C; Lu G; Kong H
Front Genet; 2022; 13():989460. PubMed ID: 36159971
[No Abstract] [Full Text] [Related]
3. Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer.
Lan T; Wang Y; Miao J; Guo H; Wang Z; Wang J; Zhang C; Yang P; Zhang Z; Dunmall LC; Wang Y
Front Mol Biosci; 2022; 9():887059. PubMed ID: 35903153
[No Abstract] [Full Text] [Related]
4. DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma.
Guo Y; Luo W; Huang S; Zhao W; Chen H; Ma Y; Ye M; Nie Y; Zhang Y; Huang C; Zhou Q; He X; Chen M
J Hepatocell Carcinoma; 2021; 8():871-885. PubMed ID: 34377684
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma.
Chen X; Yuan Y; Zhou F; Huang X; Pu J; Niu X; Jiang X; Ding X
Aging (Albany NY); 2022 Sep; 14(19):7866-7876. PubMed ID: 36170019
[TBL] [Abstract][Full Text] [Related]
6. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
8.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
9.
Tang M; Sun J; Cai Z
J Thorac Dis; 2023 May; 15(5):2601-2615. PubMed ID: 37324064
[TBL] [Abstract][Full Text] [Related]
10. ncRNA-mediated low expression of P2RY14 correlates with poor prognosis and tumor immune infiltration in ovarian carcinoma.
Shu C; Liu L; Chen X; Xue J; Fei J; Wang J; Yang X; Peng Q; Yuan H
Ann Transl Med; 2023 Jan; 11(1):10. PubMed ID: 36760244
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
13. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
Front Genet; 2022; 13():1022626. PubMed ID: 36685833
[No Abstract] [Full Text] [Related]
14. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
15. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma.
Li Y; Su Z; Wei B; Liang Z
Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
Li T; Zhao H; Zhou H; Geng T
PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
18. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
[TBL] [Abstract][Full Text] [Related]
19. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.
Wen X; Shao Z; Chen S; Wang W; Wang Y; Jiang J; Ma Q; Zhang L
Front Genet; 2020; 11():610350. PubMed ID: 33584809
[No Abstract] [Full Text] [Related]
20. Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses.
Li TH; Qin XH; Wang LQ; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
Heliyon; 2023 Oct; 9(10):e20464. PubMed ID: 37842592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]